Avalere Spotlight: Life Sciences in 2014

Share

Published

The 2014 market will be characterized by challenge and transformation across payers, providers, and patients which will create pressures for the pharmaceutical and medical device industries to:

Devise new selling strategies in anticipation of the bleed of new exchange products into commercial benefit designs.

Adapt organizational and field capabilities to bring evidence-based solutions and new contracting arrangements to integrated providers who may play a more dominant role in regional markets.

Invest in and partner to generate real-world evidence, analytics, and tools that can support clinical decision-making.

Revisit patient support strategies to be responsive to growing cost burdens on patients and new health plan messaging.

Click the button below to download the full Avalere Spotlight Life Sciences report. For more information on how Avalere can partner with you to position your business for success in 2014, please contact Reginald Williams.